Enabling multidimensional tumor immunogenomics for advancing biomarker discovery
Christelle Johnson, PhD
Senior Field Application Scientist
Enabling multidimensional tumor immunogenomics for advancing biomarker discovery
- Insight into the complex and dynamic interactions between the tumor and immune cells of the microenvironment is essential for cancer immunotherapy translational studies
- Purpose built for precision oncology, the ImmunoID NeXT Platform investigates key areas of tumor biology; from elucidating mechanisms of tumor escape and detecting neoantigens, to identifying novel signatures and characterizing the immune repertoire
- We’ll discuss the current challenges facing investigators in immuno-oncology translational research including maximizing data generation from a single sample and enabling composite biomarker discovery
